The Study of Protection of Irb on Human Umbilical Vein Endothelial Cells Impaired by Lysophosphatidylcholine

DAI Wen-Zhuo,SHI Jing-Ping,LIN Xing-Jian
2008-01-01
Abstract:Objective To investigate the protection effect of irbesartan on cultured human umbilical vein endothelial cells(HUVECs) impaired by lysophosphatidylcho-line(LPC). Methods HUVECs were cultured in vitro. The study was designated to 8 groups: (1)normal control,(2)low-concentration LPC group (10μg/L),(3)middle-concentration LPC group(20μg/ L),(4) high-concentration LPC group (40μg/L),(5)Irb control group containing LPC(20μg/ L),(6)low-concentration Irb group(10-7μmol/L),(7) middle-concentration Irb group(10-6μmol/L) ,(8) high-concentration Irb group(10-5μmol/L). Expression of angiotensin Ⅱ (ATⅡ) and ATⅡ type1 receptor(AT1R),AT type2 receptor(AT2R) mRNA were observed by radio-immunity and RT-PCR respectively. Production of nitrogen monoxidum (NO),activity of nitricoxide synthase (NOS) and superoxide dismutase (SOD) were determined by chromatometry. Also the intervention effect of Irb was observed. Results Compared with normal control group,LPC could significantly up-regulate the expression of ATⅡ and AT1R mRNA and decrease the expression of NO and the activity of NOS,SOD in a dose-dependent manner; Irb could significantly increase the expression of NO and the activity of NOS and SOD. Conclusion Irb could partly protect HUVECs function against the LPC-induced damage.
What problem does this paper attempt to address?